| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Brown Regina serves as a Director at LIXT. Across recent SEC filings that breaks down to 2 buys and 0 sells. Those positions are worth an estimated $4K at current prices.
The biggest single holding is LIXT (~$4K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 5,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | LIXT Lixte Biotechnology Holdings, Inc. | Director | Buy | 5,000 | $0.58 | $2,876.00 | +384.6% | +89.3% | -48.9% |